绒毛膜绒毛取样快速确认21、18和13三体高风险NIPT结果
国际学会推荐高风险NIPT后行羊膜腔穿刺,因CVS可能因胎盘嵌合体得出不确定结果。本研究回顾性分析2017年4月至2022年12月间338例确认性细胞遗传学结果,分离细胞滋养层与间充质核心分析。结论:CVS对21、18、13三体高风险NIPT的明确诊断率分别为97.5%、100%、86.5%;70%孕妇选择CVS作为快速确认检测;在检测前咨询不确定结果风险后,CVS和AC均可提供。
要点
- CVS对21、18、13三体高风险NIPT的明确诊断率分别为97.5%、100%、86.5%。
- 因13三体转诊者中13.5%(5/37)在间充质核心检出嵌合型三体需追加羊膜腔穿刺。
- 70%孕妇选择CVS作为快速确认检测,检测前咨询不确定结果风险后CVS和AC均可提供。
核心结论
- CVS对21、18、13三体高风险NIPT的明确诊断率分别为97.5%、100%、86.5%。
- 多数孕妇(70%)选择CVS作为快速确认检测。
- 作者结论:在检测前咨询本研究计算的不确定结果风险后,CVS和AC均可提供。
研究设计与样本
- 回顾性分析2017年4月至2022年12月的确认性细胞遗传学结果。
- 分离细胞滋养层(CTB)与间充质核心(MC),行QF-PCR和/或SNP array分析,必要时行核型分析。
- 共338例,其中70%(237/339)行CVS(70.5%),30%(101/338)行AC。
主要发现
- 因13三体转诊者中,间充质核心嵌合型三体需追加羊膜腔穿刺者占13.5%(5/37)。
- 因21三体转诊者中,间充质核心嵌合型三体需追加羊膜腔穿刺者占2.5%(4/158)。
- 因18三体转诊者中,间充质核心嵌合型三体需追加羊膜腔穿刺者占0%(0/42)。
关键数值与推荐
- CVS对21三体高风险NIPT的明确诊断率为97.5%。
- CVS对18三体高风险NIPT的明确诊断率为100%。
- CVS对13三体高风险NIPT的明确诊断率为86.5%。
临床怎么用
- 作者结论:在检测前咨询本研究计算的不确定结果风险后,CVS和AC均可提供。
- 本研究中多数孕妇(70%)选择CVS作为快速确认检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: International societies recommend amniocentesis (AC) after high-risk non-invasive prenatal testing (NIPT) because of potential inconclusive results from chorionic villus sampling (CVS) caused by placental mosaicism. Our study aimed to evaluate the necessity of confirmatory amniocentesis following CVS for trisomies 21, 18, and 13 with separate analysis of cytotrophoblast (CTB) and mesenchymal core (MC). METHODS: We retrospectively analyzed the confirmatory cytogenetic results between April 2017 and December 2022. CTB and MC were separated and analyzed by QF-PCR and/or SNP array, and karyotyping when needed. RESULTS: Among 338 cases, 70% (237/339) of women underwent CVS (70.5%) and 30% (101/338) underwent AC. Mosaic trisomy in MC requiring additional amniocentesis was detected in 13.5% (5/37) of cases referred due to trisomy 13, 2.5% (4/158) of cases of trisomy 21% and 0% (0/42) of cases of trisomy 18. CONCLUSIONS: A definitive diagnosis of CVS was achieved in 97.5%, 100%, and 86.5% of patients with high-risk NIPT results for trisomy 21, 18, and 13, respectively. Moreover, our clinical practice confirms that the majority of pregnant women (70%) opted for CVS as a quick confirmatory test. We conclude that both CVS and AC can be offered when preceded by pre-test counseling on the risks of potential inconclusive results as calculated in this study.
引用
- Srebniak MI, Weerts M, Joosten M, et al. Chorionic Villus Sampling for Rapid Confirmation of High-Risk NIPT Results for Trisomy 21, 18, and 13. Prenat Diagn. 2025. PMID: 40528522. doi:10.1002/pd.6837
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。